SKI Market

Indian Indices

Nifty

25,461.00 55.70
(0.22%)

Sensex

83,432.89 193.42
( 0.23%)

Bank Nifty

57,031.90 239.95
( 0.42%)

Nifty IT

39,166.55 312.25
( 0.80%)

Global Indices

Nasdaq

44,849.54 344.11
(0.77%)

Dow Jones

6,300.35 51.93
(0.83%)

Hang Seng

39,792.23 6.33
(0.02%)

Nikkei 225

8,822.91 -0.29
(0.00%)

Forex

USD-INR

85.44 -0.20
(-0.23%)

EUR-INR

100.61 -0.32
(-0.32%)

GBP-INR

116.59 -0.52
(-0.45%)

JPY-INR

0.59 0.00
(-0.64%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

101.444166

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

93.93

402284.5

EPS(TTM)

Face Value()

Div & Yield %

17.85

0.95

Back

Sun Pharmaceuticals Industries Ltd

Sun Pharma updates on US FDA inspection

Jun 14,2025

Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.

25,461.00 55.70 (0.22%)

83,432.89 193.42 ( 0.23%)

57,031.90 239.95 ( 0.42%)

39,166.55 312.25 ( 0.80%)

44,849.54 344.11 (0.77%)

6,300.35 51.93 (0.83%)

39,792.23 6.33 (0.02%)

8,822.91 -0.29 (0.00%)

85.44 -0.20 (-0.23%)

100.61 -0.32 (-0.32%)

116.59 -0.52 (-0.45%)

0.59 0.00 (-0.64%)